Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Here in the USA, the two main organizations representing the primary care community ( the American College of Physicians [ACP] and the American Academy of Family Physicians [AAFP]) have taken no specific position on early detection and screening for prostate cancer since the ACP issued a now “inactive” guideline in 1997.
Filed under: Diagnosis, Risk | Tagged: early detection, guideline, policy, screening | 1 Comment »
It has taken a while to get there but the Prostate Cancer Roundtable finally has its own web site up and running. This will make it a good deal easier for people to keep up to date with the shared advocacy agenda and related activities of the major, US-based, patient-centric prostate cancer organizations.
Filed under: Uncategorized | Tagged: advocacy, policy, Roundtable | Leave a Comment »
According to a media release this morning the French national health authority (HAS) has put in place a special temporary reimbursement policy that will cover the use of high intensity focused ultrasound (HIFU) only for selected uses of this technique in the management of prostate cancer.
Filed under: Management, Treatment | Tagged: France, HIFU, policy, reimbursement | 2 Comments »
According to a media release issued yesterday, “the members of the Prostate Cancer Roundtable have updated their shared, national policy agenda” which will act as the basis for discussions with U.S. policy makers in 2011 and beyond.
Filed under: Uncategorized | Tagged: agenda, policy, Roundtable | 7 Comments »
On December 23, the National Cancer Institute (NCI) issued a media release announcing a first step toward major changes in how big, cooperative clinical trials get managed and funded in the USA.
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: clinical trials, cooperative, National Cancer Institute, policy, process | Leave a Comment »
Over the next few days, hundreds of prostate cancer patients, advocates, and researchers will be gathering in DC for a series of events focused on progress against prostate cancer. And there is a shared five-point plan of action to take to Congress and the White House.
Filed under: Uncategorized | Tagged: advocacy, policy, research | Leave a Comment »
Apparently the Centers for Medicare and Medicaid Services (CMS) rescinded the “least costly alternative” policy on April 19 this year.
Filed under: Living with Prostate Cancer | Tagged: LCA, least costly alternative, policy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site